These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
955 related articles for article (PubMed ID: 402479)
1. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479 [TBL] [Abstract][Full Text] [Related]
2. Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma. Labrie F; Kelly PA; Asselin J; Raynaud JP Recent Results Cancer Res; 1976; (57):109-20. PubMed ID: 827798 [TBL] [Abstract][Full Text] [Related]
3. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors. Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. Li S; Lévesque C; Geng CS; Yan X; Labrie F Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332 [TBL] [Abstract][Full Text] [Related]
5. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats. Smith RD; Hilf R; Senior AE Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605 [TBL] [Abstract][Full Text] [Related]
7. Importance of progesterone in DNA synthesis of pregnancy-dependent mammary tumors in mice. Yanai R; Nagasawa H Int J Cancer; 1976 Sep; 18(3):317-21. PubMed ID: 986372 [TBL] [Abstract][Full Text] [Related]
8. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors. Tsai TL; Katzenellenbogen BS Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032 [TBL] [Abstract][Full Text] [Related]
9. Effect of estrone on the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in the rat: a model of postmenopausal breast cancer. Li S; Martel C; Dauvois S; Bélanger A; Labrie F Endocrinology; 1994 Mar; 134(3):1352-7. PubMed ID: 8119175 [TBL] [Abstract][Full Text] [Related]
10. Anti-implantation activity of antiestrogens and mifepristone. Dao B; Vanage G; Marshall A; Bardin CW; Koide SS Contraception; 1996 Oct; 54(4):253-8. PubMed ID: 8922879 [TBL] [Abstract][Full Text] [Related]
11. The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancer. Koibuchi Y; Sugamata N; Iino Y; Yokoe T; Andoh T; Maemura M; Takei H; Horiguchi J; Matsumoto H; Morishita Y Int J Mol Med; 1999 Aug; 4(2):145-8. PubMed ID: 10402480 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300 [TBL] [Abstract][Full Text] [Related]
13. Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis. De Jonage-Canonico MB; Lenoir V; Martin A; Scholler R; Kerdelhué B Breast Cancer Res Treat; 2003 Jun; 79(3):365-77. PubMed ID: 12846421 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of a steroidal antiestrogen (EM-170) on estrone-stimulated growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. Labrie F; Li S; Labrie C; Lévesque C; Mérand Y Breast Cancer Res Treat; 1995 Mar; 33(3):237-44. PubMed ID: 7749151 [TBL] [Abstract][Full Text] [Related]
15. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats. Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706 [TBL] [Abstract][Full Text] [Related]
16. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Thordarson G; Lee AV; McCarty M; Van Horn K; Chu O; Chou YC; Yang J; Guzman RC; Nandi S; Talamantes F Carcinogenesis; 2001 Dec; 22(12):2039-47. PubMed ID: 11751437 [TBL] [Abstract][Full Text] [Related]
17. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat. Luo S; Sourla A; Labrie C; Bélanger A; Labrie F Endocrinology; 1997 Oct; 138(10):4435-44. PubMed ID: 9322961 [TBL] [Abstract][Full Text] [Related]
18. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat. Gandilhon P; Melancon R; Djiane J; Kelly PA J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats. Luo S; Stojanovic M; Labrie C; Labrie F Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575 [TBL] [Abstract][Full Text] [Related]
20. Mammary tumorigenesis in chemical carcinogen-treated mice. VII. Prolactin and progesterone levels in BALB/c mice. Medina D; O'Bryan SB; Warner MR; Sinha YN; VanderLaan WP; McCormack S; Hahn P J Natl Cancer Inst; 1977 Jul; 59(1):213-9. PubMed ID: 406413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]